Foghorn Therapeutics Inc. - COMMON STOCK (FHTX)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
55,781,559
Total 13F shares
26,307,921
Share change
+20,630
Total reported value
$225,720,907
Price per share
$8.58
Number of holders
60
Value change
+$12,954
Number of buys
25
Number of sells
20

Institutional Holders of Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) as of Q3 2022

As of 30 Sep 2022 Foghorn Therapeutics Inc. - COMMON STOCK (FHTX) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 26,307,921 shares of stock of the company.
Largest 10 holders included Flagship Pioneering Inc., FMR LLC, Artal Group S.A., Euclidean Capital LLC, BlackRock Inc., MORGAN STANLEY, VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Alphabet Inc., and Point72 Asset Management, L.P..
This table shows 60 institutional shareholders of the security as of 30 Sep 2022.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.